Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.3K
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IIC-DTI: A Contrastive Learning Enhanced Inter-Intra Molecular Fusing Framework for Drug-Target Interaction Prediction.

Interdisciplinary sciences, computational life sciences·2026
Same author

MotifGT-DTI: Pivotal Motif-Based Graph Transformer Model Improves Drug--Target Interaction Prediction.

IEEE transactions on neural networks and learning systems·2026
Same author

Graph convolution network based on meta-paths and mutual information for drug-target interaction prediction.

BMC bioinformatics·2025
Same author

The study of the variation of mineral distribution and relative concentration on varieties of oat using synchrotron-based X-ray fluorescence imaging.

Food research international (Ottawa, Ont.)·2025
Same author

Predicting miRNA-Drug Interactions Based on Multi-source Feature Fusion of Heterogeneous Network.

Interdisciplinary sciences, computational life sciences·2025
Same author

Low-Count PET Image Reconstruction With Generalized Sparsity Priors via Unrolled Deep Networks.

IEEE journal of biomedical and health informatics·2025

Related Experiment Video

Updated: Dec 25, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

DMFLDA: A Deep Learning Framework for Predicting lncRNA-Disease Associations.

Min Zeng, Chengqian Lu, Zhihui Fei

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |April 6, 2020
    PubMed
    Summary

    This study introduces DMFLDA, a novel deep matrix factorization model for predicting long non-coding RNA (lncRNA)-disease associations. DMFLDA effectively captures complex non-linear relationships, outperforming existing methods and aiding disease research.

    More Related Videos

    Constructing and Visualizing Models using Mime-based Machine-learning Framework
    06:19

    Constructing and Visualizing Models using Mime-based Machine-learning Framework

    Published on: July 22, 2025

    2.0K
    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    1.2K

    Related Experiment Videos

    Last Updated: Dec 25, 2025

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    2.0K
    Constructing and Visualizing Models using Mime-based Machine-learning Framework
    06:19

    Constructing and Visualizing Models using Mime-based Machine-learning Framework

    Published on: July 22, 2025

    2.0K
    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    1.2K

    Area of Science:

    • Genomics
    • Bioinformatics
    • Computational Biology

    Background:

    • Long non-coding RNAs (lncRNAs) are implicated in human diseases, but experimentally verified associations are scarce.
    • Existing computational methods for predicting lncRNA-disease associations have limitations in capturing non-linear relationships and learning effective representations.

    Purpose of the Study:

    • To develop a novel computational model, Deep Matrix Factorization for lncRNA-Disease Associations (DMFLDA), to predict lncRNA-disease associations.
    • To overcome the limitations of current matrix factorization and machine learning methods in representing complex lncRNA-disease interactions.

    Main Methods:

    • DMFLDA employs a cascade of non-linear hidden layers to learn latent representations for lncRNAs and diseases.
    • The model directly learns features from the lncRNA-disease interaction matrix, enabling more accurate representation learning.
    • Low-dimensional representations are fused to predict new interaction values.

    Main Results:

    • DMFLDA demonstrated superior performance compared to existing methods in leave-one-out and 5-fold cross-validation.
    • Case studies confirmed predicted lncRNA-disease associations for colorectal cancer, prostate cancer, and renal cancer, supported by recent literature.

    Conclusions:

    • DMFLDA effectively predicts lncRNA-disease associations by capturing complex non-linear relationships.
    • The model offers a powerful tool for advancing research in lncRNAs and their roles in human diseases.
    • The developed model and datasets are publicly available for further research.